PL2978764T3 - Pochodne pirazolonaftyrydynonu jako inhibitory METAP2 (aminopeptydazy metioniny typu 2) - Google Patents
Pochodne pirazolonaftyrydynonu jako inhibitory METAP2 (aminopeptydazy metioniny typu 2)Info
- Publication number
- PL2978764T3 PL2978764T3 PL14711524T PL14711524T PL2978764T3 PL 2978764 T3 PL2978764 T3 PL 2978764T3 PL 14711524 T PL14711524 T PL 14711524T PL 14711524 T PL14711524 T PL 14711524T PL 2978764 T3 PL2978764 T3 PL 2978764T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrazolonaphthyridinone
- derivatives
- methionine aminopeptidase
- metap2 inhibitors
- aminopeptidase type
- Prior art date
Links
- 101710181812 Methionine aminopeptidase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- YJTVMKYUFDOGJU-UHFFFAOYSA-N pyrazolo[4,3-b][1,8]naphthyridin-3-one Chemical class N1=NC(C=2C1=CC=1C=CC=NC1N2)=O YJTVMKYUFDOGJU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305365 | 2013-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2978764T3 true PL2978764T3 (pl) | 2017-09-29 |
Family
ID=48040135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14711524T PL2978764T3 (pl) | 2013-03-25 | 2014-03-21 | Pochodne pirazolonaftyrydynonu jako inhibitory METAP2 (aminopeptydazy metioniny typu 2) |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9856257B2 (pl) |
| EP (1) | EP2978764B1 (pl) |
| JP (1) | JP2016515541A (pl) |
| KR (1) | KR20150135406A (pl) |
| CN (1) | CN105246893B (pl) |
| AU (1) | AU2014243257A1 (pl) |
| BR (1) | BR112015024189A2 (pl) |
| CA (1) | CA2907532A1 (pl) |
| DK (1) | DK2978764T3 (pl) |
| ES (1) | ES2633440T3 (pl) |
| IL (1) | IL241447A0 (pl) |
| MX (1) | MX2015013740A (pl) |
| PL (1) | PL2978764T3 (pl) |
| PT (1) | PT2978764T (pl) |
| RU (1) | RU2015145479A (pl) |
| SG (1) | SG11201507519RA (pl) |
| WO (1) | WO2014154586A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201406486D0 (en) * | 2014-04-10 | 2014-05-28 | Redx Pharma Ltd | Antibacterial compounds |
| US10105349B2 (en) * | 2014-12-06 | 2018-10-23 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR102557603B1 (ko) | 2014-12-06 | 2023-07-19 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| WO2017046606A1 (en) * | 2015-09-18 | 2017-03-23 | Redx Pharma Plc | Antibacterial compounds |
| TWI782056B (zh) | 2017-07-14 | 2022-11-01 | 日商鹽野義製藥股份有限公司 | 具有ｍｇａｔ２抑制活性的縮合環衍生物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080046728A (ko) * | 2005-09-15 | 2008-05-27 | 아스카 세이야쿠 가부시키가이샤 | 복소환 화합물, 그의 제조 방법 및 용도 |
| AR068063A1 (es) * | 2007-08-27 | 2009-11-04 | Basf Plant Science Gmbh | Co mpuestos de pirazol para controlar plagas de invertebrados |
| JP5941981B2 (ja) | 2011-05-06 | 2016-06-29 | ザフゲン，インコーポレイテッド | 三環式スルホンアミド化合物ならびにその製造および使用方法 |
| US9169246B2 (en) | 2011-09-26 | 2015-10-27 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| US20140235616A1 (en) | 2011-09-26 | 2014-08-21 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| EP2573073B1 (en) * | 2011-09-26 | 2014-10-22 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
-
2014
- 2014-03-21 PT PT147115240T patent/PT2978764T/pt unknown
- 2014-03-21 CN CN201480029260.XA patent/CN105246893B/zh not_active Expired - Fee Related
- 2014-03-21 US US14/778,948 patent/US9856257B2/en not_active Expired - Fee Related
- 2014-03-21 DK DK14711524.0T patent/DK2978764T3/en active
- 2014-03-21 EP EP14711524.0A patent/EP2978764B1/en not_active Not-in-force
- 2014-03-21 ES ES14711524.0T patent/ES2633440T3/es active Active
- 2014-03-21 KR KR1020157030319A patent/KR20150135406A/ko not_active Application Discontinuation
- 2014-03-21 PL PL14711524T patent/PL2978764T3/pl unknown
- 2014-03-21 RU RU2015145479A patent/RU2015145479A/ru not_active Application Discontinuation
- 2014-03-21 AU AU2014243257A patent/AU2014243257A1/en not_active Abandoned
- 2014-03-21 MX MX2015013740A patent/MX2015013740A/es unknown
- 2014-03-21 BR BR112015024189A patent/BR112015024189A2/pt not_active Application Discontinuation
- 2014-03-21 CA CA2907532A patent/CA2907532A1/en not_active Abandoned
- 2014-03-21 WO PCT/EP2014/055719 patent/WO2014154586A1/en active Application Filing
- 2014-03-21 SG SG11201507519RA patent/SG11201507519RA/en unknown
- 2014-03-21 JP JP2016503675A patent/JP2016515541A/ja active Pending
-
2015
- 2015-09-10 IL IL241447A patent/IL241447A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2978764T (pt) | 2017-07-17 |
| IL241447A0 (en) | 2015-11-30 |
| JP2016515541A (ja) | 2016-05-30 |
| BR112015024189A2 (pt) | 2017-07-18 |
| CA2907532A1 (en) | 2014-10-02 |
| EP2978764B1 (en) | 2017-04-19 |
| MX2015013740A (es) | 2016-02-29 |
| WO2014154586A1 (en) | 2014-10-02 |
| DK2978764T3 (en) | 2017-07-31 |
| CN105246893B (zh) | 2017-10-27 |
| ES2633440T3 (es) | 2017-09-21 |
| SG11201507519RA (en) | 2015-10-29 |
| AU2014243257A1 (en) | 2015-10-15 |
| EP2978764A1 (en) | 2016-02-03 |
| US20160060265A1 (en) | 2016-03-03 |
| KR20150135406A (ko) | 2015-12-02 |
| CN105246893A (zh) | 2016-01-13 |
| US9856257B2 (en) | 2018-01-02 |
| RU2015145479A (ru) | 2017-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1221466A1 (zh) | 作為 抑制劑的聯吡唑衍生物 | |
| AR095266A1 (es) | Inhibidores de bromodominios tetraciclicos | |
| HK1219475A1 (zh) | 腦啡肽酶抑制劑 | |
| HK1216531A1 (zh) | 新的抑制劑 | |
| GB201317609D0 (en) | Inhibitor compounds | |
| EP2991654A4 (en) | NOVEL CONNECTIONS AS AN ERK HEMMER | |
| HK1222339A1 (zh) | 金屬-β-內酰胺酶的抑制劑 | |
| EP2961403A4 (en) | HETEROCYCLIC INHIBITORS OF SODIUM CHANNEL | |
| IL241447A0 (en) | Pyrazolonenaphthyridinone derivatives as 2metap (methionine aminopeptidase type 2) inhibitors | |
| IL244029B (en) | Deoxycytodine kinase inhibitors | |
| HK1222582A1 (zh) | 用於改善膀胱尿道協同失調的藥劑 | |
| DOS2014000147S (es) | Envases / (parte de) | |
| UA31214S (uk) | Упаковка для сигарет | |
| GB201321328D0 (en) | Inhibitor compounds | |
| UA31604S (uk) | Упаковка для сигарет | |
| UA29169S (uk) | Упаковка для сигарет | |
| GB201305503D0 (en) | Inhibitor |